Properties
Description
A triantennary GalNAc ligand known as GalNAc-L96, which efficiently binds to ASGPR, supports the targeted synthesis of GalNAc-siRNA, thereby boosting hepatocyte targeting. L2 enhances the efficiency of GalNAc-L96 synthesis, particularly in creating targeted therapeutic agents.
Molecular Formula
41H39NO6
Purity
≥98%, determined by HPLC.
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Conforms to structure, determined by 1H NMR.